title: 5-fluorouracil exposure during the period of conception: report on two cases.
abstract: Two patients who were administered topical vaginal 5-fluorouracil for human papilloma virus lesions became pregnant during treatment. The outcomes in both cases were healthy with normal developmental landmarks at 6 months of age. This experience highlights the potential for a positive outcome.
authors.affiliation: Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta 30912.
authors.forename: L D
authors.initials: LD
authors.lastname: Odom
authors.forename: L
authors.initials: L
authors.lastname: Plouffe
authors.forename: W J
authors.initials: WJ
authors.lastname: Butler
mesh_terms: D000282:Administration, Intravaginal; D000328:Adult; D005260:Female; D005306:Fertilization; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D027383:Papillomaviridae; D011247:Pregnancy; D011256:Pregnancy Outcome; D014412:Tumor Virus Infections / Q000188:drug therapy*
chemical_list: D005472:Fluorouracil